Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
~85 mi.
(Yekaterinburg,
Russia,
+163 more cities)
Sverdlovsk Regional Oncology Hospital ( Site 0874)
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
~85 mi.
(Yekaterinburg,
Russia,
+158 more cities)
Sverdlovsk Regional Oncology Hospital ( Site 1909)
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
~85 mi.
(Yekaterinburg,
Russia,
+122 more cities)
Sverdlovsk Regional Oncology Hospital ( Site 1807)
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)
~85 mi.
(Yekaterinburg,
Russia,
+126 more cities)
Sverdlovsk Regional Oncology Hospital ( Site 0411)
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
~85 mi.
(Yekaterinburg,
Russia,
+145 more cities)
Sverdlovsk Regional Oncology Hospital ( Site 2012)